Search academic texts

Information × Registration Number 0213U003098, 0110U000165 , R & D reports Title Optimize diagnostic and experimentally justify new approaches to treatment of sensorineural hearing loss popup.stage_title Head Timen Grigory Eliazarovich, Доктор медичних наук Registration Date 23-01-2013 Organization Kiyv Research Institute of Otolaryngology named after prof. O.S.Kolomiychenko popup.description2 Study of Glutargin and trofin, the condition of the inner ear of guinea pigs after experimentally induced acute and chronic aminoglycoside ototoksykozu was conducted on 93 sexually mature animals. As a result of morphological studies, it was found that intramuscular injection trofinu and intraperitoneal administration Glutargin and trofinu completely neutralize the action of gentamicin. These data were confirmed using a functional diagnostic method (UAE). In the department of otolaryngology - diseases of childhood were treated 112 children and 64 primary - the control group. 64 patients the main group were more tests - CT temporal bone MRI of the brain using ultrasound program CISS3D and vessels of the head and neck. Pathological changes in CT available in 32% with MRI - in 18.6%, and ultrasound - in 95% of children surveyed with SNP and deafness. The developed scheme, in the first 11 days, patients performed intravenous administration rheosorbilact, piracetam, Glutargin, aminophylline, dexamethasone, vitamin C, intramuscular injections - B vitamins (B1, B6), cerebrolysin and oral betaserku (after 14 years), respectively age units. Physiotherapy presented endouralnym phonophoresis dibasol and novocaine. After being discharged from hospital patients continued to rate vitamin (milhama), oral Glutargin, betaserku and started drinking and Olatropil Cavinton within 14 days. The course of treatment with SNP lasted an average of 25 days. Patients of the control group did not receive Glutargin. The results of treatment were assessed in 25 - 30 days. The comparison results audiometrical examination of patients before and after treatment showed that a statistically significant improvement auditory function (pU <0,01), obtained in patients of group that a course of therapy with the inclusion protynevrytnoyi Glutargin at and degree of acute and when I, II and III grade chronic form SNP (stable flow) and in the control group this result was observed only in patients with acute forms and degrees SNP. Product Description popup.authors Бєлоусова А.О. Бєлякова І.А. Вінничук П.В. Кудь Л.А. Руденька К.Л. Чащева О.Г. Чубко С.П. popup.nrat_date 2020-04-02 Close